Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
TREM2 is a receptor for lipids expressed in microglia. The R47H variant of human TREM2 impairs ligand binding and increases Alzheimer’s disease (AD) risk. In mouse models of amyloid β (Aβ) accumulation, defective TREM2 function affects microglial response to Aβ plaques, exacerbating tissue damage, whereas TREM2 overexpression attenuates pathology. Thus, AD may benefit from TREM2 activation. Here, we examined the impact of an anti-human TREM2 agonistic mAb, AL002c, in a mouse AD model expressing either the common variant (CV) or the R47H variant of TREM2. Single-cell RNA-seq of microglia after acute systemic administration of AL002c showed induction of proliferation in both CV- and R47H-transgenic mice. Prolonged administration of AL002c reduced filamentous plaques and neurite dystrophy, impacted behavior, and tempered microglial inflammatory response. We further showed that a variant of AL002c is safe and well tolerated in a first-in-human phase I clinical trial and engages TREM2 based on cerebrospinal fluid biomarkers. We conclude that AL002 is a promising candidate for AD therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AL002 (27) is a TREM2-specific monoclonal antibody that activates TREM2 to enhance microglial function, thereby reducing Aβ plaque formation and attenuating neurite dystrophy.474”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [474]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“enhancing TREM2 signaling by TREM2 agonist antibody, direct delivery of the TREM2 gene, or stimulating other pathways to increase TREM2 expression in the brains of AD mice enhanced Aβ phagocytosis and improved cognitive behaviors.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [172]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging evidence has shown that TREM2 activation increased Aβ phagocytosis, relieved neuroinflammation, and improved cognitive behavior in AD mouse models.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [172]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an AD mouse model, administration of AL002c, a variant of the AL002 antibody, attenuated tau plaques and neurite dystrophy, improved behavior, and reduced microglial inflammation.537”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [537]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The opposite phenotypes observed in PLCG2 KO iMGs and Plcγ2-P522R KI mice also support the notion to therapeutically stimulate TREM2 functions [6, 16, 17, 43].”
From The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions (2020) · cites this paper as [17]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Self-citationDissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“In this model, plaques become clearly detectable at 3–4 mo of age and continue to grow for several months (Oakley et al., 2006).”
MethodAlzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Single-cell transcriptomic analysis of Alzheimer’s disease
Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1195-2 · Cited by 2,568
Cited by
Items 401–500 of 579
Neuroimmune Dysfunction in Alzheimer’s Disease and Other Forms of Dementia
Yamane, T., Yoshioka, T., & Shimo, Y. (2024) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c23-00464 · Cited by 5
Targeting TREM2 signaling shows limited impact on cerebrovascular calcification
Sridhar, S., Zhou, Y., Ibrahim, A., Bertazzo, S., Wyss, T., Swain, A., Maheshwari, U., Huang, S., Colonna, M., & Keller, A. (2024) · Life Science Alliance · doi:10.26508/lsa.202402796 · Cited by 4
Self-citationTyrphostin AG538 inhibits platelet activation and thrombosis via TREM2 agonism
Liu, Q., Yang, Q., Wang, Y., Liu, C., Jin, M., Chen, D., & Ding, Z. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117379 · Cited by 4
Lu, H., Xue, C., Zhao, Y., Sun, J., Zhao, C., Zhang, X., Zhao, G., Liu, Y., Liu, H., Deng, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202412227 · Cited by 6
Mertk promotes early microglial-mediated synaptic engulfment in Alzheimer's disease
Wu, Y., Fan, Y., Bao, S., Song, Y., Wang, R., Wu, J., Liu, X., Jin, J., Kong, L., Hou, B., et al. (2025) · Theranostics · doi:10.7150/thno.116797 · Cited by 4
Antibody drug conjugates in Alzheimer’s disease: emerging strategies and future directions
AmeliMojarad, M., & AmeliMojarad, M. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.053 · Cited by 3
TREM2 as a possible link between Alzheimer's disease and diabetes mellitus
Chen, W., Huang, N., Huang, W., Wang, M., Luo, Y., & Huang, J. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115739 · Cited by 3
He, C., Shi, H., Yu, Z., Jiao, Z., Li, J., & Yang, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1804207 · Cited by 5
Yang, K., Ma, X., Wang, B., Fan, A., Gao, H. T., Yang, Y., Li, H., Zhu, X., Hu, W., Ni, J., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.08.040 · Cited by 3
Pathological Roles of INPP5D in Alzheimer’s Disease
Chu, Y. N., Akahori, A., Takatori, S., & Tomita, T. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-31978-5_30 · Cited by 4
Emerging Microglial Therapies and Targets in Clinical Trial
Yan, L., & Crotti, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_35 · Cited by 3
Exploring the orphan immune receptor TREM2 and its non-protein ligands: In silico characterization
Dantas, P. H. D. S., Costa, V. A. F., Felice, A. G., Sousa, E. G., Matos, A. D. O., Soares, S. D. C., Silva‐Sales, M., Neves, B. J., & Sales‐Campos, H. (2024) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2024.105449 · Cited by 3
Unraveling the Controversy: The Causal Link Between Osteoarthritis and Alzheimer's Disease
Di, J., Xi, Y., Liu, Y., Qi, L., Chen, T., Chen, S., & Xiang, C. (2025) · Brain and Behavior · doi:10.1002/brb3.70455 · Cited by 3
Ramos, J. M. P., Kviatcovsky, D., & Schwartz, M. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15609 · Cited by 3
Nonpharmacological therapies for neurodegenerative disorders
Siddiq, A., Shrestha, S., Das, M., Chodnekar, S. Y., Wadan, A. S., Ayad, Y. W., & Ashraf, G. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00021-0 · Cited by 4
Eskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez, E., Laurent, C. D. S., Cortez, L. M., Patel, Z. H., Sidhu, G., Sarkar, S., Aghanya, V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.04.547548 · Cited by 3
Gao, L., Xinying, G., Qin, J., Ziwen, S., Xingrong, S., & Lei, P. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115599 · Cited by 2
Wang, Y., Wang, Q., Li, R., Yu, Y., Feng, S., Wu, W., & Ren, S. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107185 · Cited by 2
Lifestyle shapes preclinical social and microglial deficits in an Alzheimer’s disease mouse model
Ehret, F., Doludda, B., Liu, H., Nexhipi, S., Huang, H., Rost, F., Overall, R. W., Barde, W., Rünker, A. E., Sieweke, M. H., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03368-4 · Cited by 2
CD11c+ microglia: From basic research to clinical application
Zhou, Z., Zhao, Y., Fan, X., Zhang, J., Niu, R., Ma, Y., Xie, F., Tang, P., Mei, X., Zhang, L., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00868 · Cited by 2
Mechanisms and therapeutic potential of migrasomes in neurological disorders
Zhang, S., Yang, Y., Zhang, T., Pan, Y., Xu, Q., & Lü, P. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112389 · Cited by 2
Bivona, G., & Ghersi, G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073295 · Cited by 2
Tang, S., Fu, G., Yu, W., Zhou, M., Chen, T., Song, Z., Cheng, S., & Li, P. (2026) · Brain Sciences · doi:10.3390/brainsci16050443 · Cited by 2
AI-driven insights into protein misfolding and innate immunity in neurodegenerative diseases
Deng, H. X., Cao, J. L., Yao, W., Jiang, S. J., Fang, Q. Q., Zhu, B. Y., & Jiang, Y. J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1814357 · Cited by 2
Neuroprotective effects of ursodeoxycholic acid in Parkinson's disease and Alzheimer's disease
Chong, A. E. Y., Sasmita, A. O., Koh, R. Y., & Ling, A. P. K. (2026) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70039 · Cited by 2
Yao, M., Liu, A., Song, J., Xing, L., Zi, M., & Li, H. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.06.001 · Cited by 3
Cho, S., & Gabr, M. T. (2026) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2026.130712 · Cited by 2
Glucose metabolic reprogramming: mechanisms and therapeutic implications in neuroinflammation
Zhang, L., Yang, X., & Ai, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1737175 · Cited by 2
Xing, J. F., Mu, K., Xue, Y., Yang, X., Zhang, D., Gao, W., Zhang, T., Yang, S., Wang, R., Zhang, W., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1843978 · Cited by 2
Mikołajczak, K., Chmiel, J., & Leszek, J. (2026) · Cells · doi:10.3390/cells15121111 · Cited by 3
Early-stage research and new pharmacological targets in Alzhei-mer's dementia
Grecu, M., Romila, A., Moldovanu, S., Condratovici-Plesa, A., Anghel, L., Oprea, V. D., & Bocancia, L. A. (2026) · Balneo and PRM Research Journal · doi:10.12680/balneo.2026.1024 · Cited by 3
Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00571-3 · Cited by 2
Du, J. T., Chartrand, T., Jayadev, S., Prater, K. E., & Lin, K. (2026) · Journal of Computational Biology · doi:10.1177/15578666261492321 · Cited by 2
Gibbons, L., & Curtis, D. (2025) · Journal of Neurogenetics · doi:10.1080/01677063.2025.2522643 · Cited by 2
“Current and emerging drug therapies in Alzheimer’s disease: A pathophysiological Perspective”
Aparajita, A., Jain, U., & Srivastava, P. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.078 · Cited by 2
Wan, Y., Kang, Q., Zhang, J., Yu, C., Fang, S., Zou, D., & Chai, W. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.103996 · Cited by 2
Jinglei, J., Tao, Y., Yulin, Q., & Wang, M. (2025) · PubMed Central · doi:10.19852/j.cnki.jtcm.20250327.002 · Cited by 3
Dual Role of Microglial TREM2 in Neuronal Degeneration and Regeneration after Axotomy
Pottorf, T. S., Lane, E. L., Haley-Johnson, Z., Ukmar, D. N., Amores-Sanchez, V., Correa-Torres, P. M., & Álvarez, F. J. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.0112-26.2026 · Cited by 2
Cholesterol and obesity: A marker for Alzheimer’s disease
Sumithra, M., & Ancy, P. M. (2022) · Annals of Phytomedicine An International Journal · doi:10.54085/ap.2022.11.1.27 · Cited by 2
Ma, W., Zhao, L., Xu, B., Fariss, R. N., Redmond, T. M., Zou, J., Wong, W. T., & Li, W. (2023) · eLife · doi:10.7554/elife.90695.1 · Cited by 3
Ma, W., Zhao, L., Xu, B., Fariss, R. N., Redmond, T. M., Zou, J., Wong, W. T., & Li, W. (2024) · eLife · doi:10.7554/elife.90695.2 · Cited by 3
Immunotherapy of Alzheimer’s Disease
Tondo, G., Marchi, F. D., Anselmi, M., & Comi, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_51 · Cited by 1
Carpanini, S. M., Bradford, B. M., Alfieri, A., Piccardo, P., Monzón‐Sandoval, J., Brown, D., Boyle, A., Pokrovskaya, A., Mabbott, N. A., Manson, J. C., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1525017 · Cited by 2
Myers, S. J., Medapati, M. R., Allman, B. L., Pasternak, S., Whitehead, S. N., & Roseborough, A. D. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101261 · Cited by 1
Zhang, Y., Guo, X., Zhao, J., Gao, X., Zhang, L., Huang, T., Wang, Y., Niu, Q. L., & Zhang, Q. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04790-z · Cited by 1
Neuroimmune Crosstalk in Neurodegenerative Diseases: Pathogenic Mechanisms and Therapeutic Potential
Olayemi, O. E., Oyesola, O., Bamgbose, O. A., & Sobowale, Z. (2025) · Multidisciplinary Journal of Horseed International University (MJHIU) · doi:10.59336/6aw8yr31 · Cited by 1
Integrative analysis of pooled CRISPR screens provide functional insights into AD GWAS risk genes
Wang, R. Y., Wozniak, G. G., Wang, X., Mustafa, M., Khatib, M. E., Kahn, E., Heutink, P., Long, H., Kenkare-Mitra, S., Rosenthal, A., et al. (2026) · iScience · doi:10.1101/2025.07.17.660041 · Cited by 1
Self-citationMapping microglial mechanisms in Alzheimer’s disease: a comprehensive analysis
Wang, X., Guo, Y., Zha, Y., Wang, S., Yang, W., & Jia, Q. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10808 · Cited by 1
Self-citationProteome-wide association study identifies novel Alzheimer's disease-associated proteins
Sun, L., Wei, G., Ji, F., Ding, Y., Fan, J., Xu, Y., He, C., Zhou, Y., Liu, Z., Sun, Z., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251409352 · Cited by 1
Harnessing the microbiome to regulate myeloid TREM2 expression and innate immune responses
Mihori, S., Nichols, F. C., Jellison, E. R., Blesso, C. N., Graziano, V. R., Rathinam, V. A. K., & Clark, R. B. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlaf073 · Cited by 1
Shu, X., Zeng, J., & Zhang, K. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-025-01582-2 · Cited by 1
The TREM2 T96K paradox: Stronger signaling in vitro, weaker microglia in vivo
Penati, S., & Colonna, M. (2026) · Neuron · doi:10.1016/j.neuron.2025.12.041 · Cited by 1
Self-citationDreschnack, I., & Dreschnack, P. A. (2025) · Medical Research Archives · doi:10.18103/mra.v14i1.7229 · Cited by 1
Anti-amyloid antibody therapies for Alzheimer's disease: how much do we really understand?
Chen, Y. (2026) · Targetome · doi:10.48130/targetome-0026-0004 · Cited by 1
Datta, D., Wang, M., & Arnsten, A. F. T. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1750092 · Cited by 1
Wang, H., He, Y., Ling, J., Li, Q., Quan, J., Zou, P., Wang, X., Shen, W., Li, Y., & Qu, Z. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174544 · Cited by 4
Kim, D., Kondo, T., Imamura, K., Tsukita, K., Nagahashi, A., Sakasai, T., & Inoue, H. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71074 · Cited by 1
Li, X.-Y., Zhang, Y., Ran, Z., Luo, J.-X., Yu, X.-Q., & Lu, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05886-w · Cited by 1
Hirota, Y., Yamamoto, J., Takatori, S., Sakakibara, Y., Takei, K., 佐治多美子, Sekiya, M., Tomita, T., & Iijima, K. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00032-1 · Cited by 1
Efferocytosis: Signaling Pathways and New Therapeutic Strategies for Diseases
Wang, L., Ge, J., Wang, Z., Fang, Y., Jia, Y., Zhang, R., & Qin, Y. (2026) · MedComm · doi:10.1002/mco2.70764 · Cited by 1
Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice
Sharma, A., 瀬川英美子, Chen, X., Park, S., Wang, S., Irmen, R. E., Constantino, N. J., Wang, C., Kanan, M. F., Colonna, M., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00948-y · Cited by 1
Self-citationMicroenvironmental Regulation of Central Nervous System Myelination and Remyelination
Wang, Y., Tan, L., Lao, L., Huang, X., Zhang, S., & Sun, H. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin43257 · Cited by 1
TREM2 restrains myeloid inflammasome activation to protect against photoreceptor degeneration
wang, T., Su, L., Szczepan, M., Wang, X., Gregg, A. T., Guo, J., Smith, L. E. H., & Sun, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03903-2 · Cited by 1
Human Microglial Molecular Alterations in Aging and Alzheimer’s Disease
Baldo, K. A. T., Gozlan, E., Chidebe, E. O., Awogbindin, I. O., Prieto, M. O., Dalmacio, L. M. M., Ben-Azu, B., Frenkel, D., & Tremblay, M. (2026) · Cells · doi:10.3390/cells15131159 · Cited by 1
Zhang, J., Yang, N., Zou, P., & Zong, X. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03924-x · Cited by 2
Advances in Tricyclic Compounds for the Treatment of Alzheimer's Disease
Shi, Y., 廖心丹, & Yu, G. (2026) · ChemMedChem · doi:10.1002/cmdc.70384 · Cited by 1
Is amyloid beta peptide a driver of inflammaging?
Kechko, O. I., Moskalev, A. A., Franceschi, C., Mitkevich, V. A., & Makarov, A. А. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103280 · Cited by 1
Lei, Y., Liu, L., & Tang, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103287 · Cited by 1
Cui, Q., Zheng, K., Liu, Q., Wang, L., Liu, Y., Bai, R., Zhang, W., Guo, J., Chang, X., & Wang, J. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1921079 · Cited by 1
Yu, X., Ren, Q., Gao, Y., Xie, S., Dang, R., Meng, J., Su, Z., Li, M., Ao, Y., Liu, A., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118063 · Cited by 1
Dejanovic, B., Figley, M. D., Weisman, E. F., Kiragasi, B., Gergits, F. W., Larson, K., Renoux, A. J., Rajagovindan, R., Pandya, B. A., Houze, J. B., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aec5740 · Cited by 2
Self-citationThe future of dementia prevention and treatment strategies
直行, 里. (2020) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.57.374 · Cited by 1
Liu, X., Du, S.-C., Jiang, F., Jiang, P., & Liu, Y. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp01083j · Cited by 1
Research on acupuncture and glial cells: A bibliometric analysis
Liu, Q., Ai, K., Jiang, X., Yang, H. J., Chen, L., Cao, S.-H., He, H.-L., Liu, X., & Liu, M. (2024) · Medicine · doi:10.1097/md.0000000000038898 · Cited by 1
Therapeutic Strategies in Neurodegenerative Diseases
Eid, A. M., Faridar, A., & Appel, S. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_39 · Cited by 2
Sandhu, J. K., Thakur, K., Cai, D., Péladeau, C. L., Hewitt, M., & Ghadban, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00055-3 · Cited by 1
Effects of Hesperetin Early Intervention on Brain Neurons and Microglia in APPswe/PS1dE9 Mice
Wang, N., Wen, H., Sun, Y., Xu, W., Shen, X., & Wang, R. (2026) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273418623251203072424 · Cited by 1
Geller, A., Kwon, M. J., Simmons, S., Xu, Q., Martenis, W. E., Doman, J. L., Natarajan, S., Stalnaker, K. J., Zhang, J., Adiconis, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.26.690816 · Cited by 1
Li, N. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00808-4 · Cited by 1
Microglia, TREM2, and Therapeutic Methods of Alzheimer’s Disease
Xu, S., Ji, Y., Sha, T., & Li, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100203
Activation of Microglia and Macrophages in Neurodegenerative Diseases
Salamero‐Boix, A., Schulz, M., & Sevenich, L. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_2
Rubinski, A., Frerich, S., Malik, R., Franzmeier, N., Ramírez, A., Dichgans, M., Ewers, M., & Initiative, A. D. N. (2021) · medRxiv · doi:10.1101/2021.11.02.21265788
江本, 拓., 山下, 智., & Hirata, K. (2022) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.31.0_11
The role of microglia in Alzheimer’s Disorder
Guo, X., Lan, H., & Liao, J.-B. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v54i.9763
Eskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez, E., Laurent, C. D. S., Cortez, L. M., Patel, Z. H., Sidhu, G., Sarkar, S., Aghanya, V., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3147035/v1
Ehret, F., Doludda, B., Liu, H., Nexhipi, S., Huang, H., Barde, W., Rost, F., Overall, R. W., Dahl, A., Schmidt, M. H. H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.23.576790 · Cited by 1
TIM-3 blockade as a therapeutic approach for diffuse intrinsic pontine glioma
Ausejo-Mauleón, I. (. (2023) · Depósito Académico Digital Universidad de Navarra (University of Navarra) · doi:10.15581/10171/69095
Doença de Alzheimer: uso do biomarcador de imagem e biomarcador fluido para o diagnóstico precoce
Yu, C. H. Y., & Bignardi, P. R. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n1-378 · Cited by 1
Lillo, S. (2023) · theses.fr (ABES) · doi:10.70675/49be81c2z656fz400dzbc64z391cf8330a65
TREM2 inhibits rTp47-induced inflammasome activation and pyroptosis via targeting NLRP3Preprint
Weng, W., Chang, L., Li, Z., Bai, R., Li, J., Zhang, M., Huang, X., & Gao, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4339591/v1
Ma, W., Zhao, L., Xu, B., et al. (2024) · eLife · doi:10.7554/elife.90695.2.sa1
Ma, W., Zhao, L., Xu, B., et al. (2024) · eLife · doi:10.7554/elife.90695.2.sa2
Ma, W., Zhao, L., Xu, B., Fariss, R. N., Redmond, T. M., Zou, J., Wong, W. T., & Li, W. (2024) · eLife · doi:10.7554/elife.90695.2.sa0
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00023-1
Human genetics: Establishment of cause-and-effect relationships
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00013-9
Immune Transformations for Therapeutic Gain in Neurodegenerative Disease
Sapkota, R., & Mosley, R. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_50
Axon regeneration after spinal cord and brain injuries
McCrea, M. R., & Li, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15580-2.00023-0
Metadata
- Authors
- Wang, S., Mustafa, M., Yuede, C. M., Salazar, S. V., Kong, P., Long, H., Ward, M., Siddiqui, O., Paul, R., Gilfillan, S., Ibrahim, A., Rhinn, H., Tassi, I., Rosenthal, A., Schwabe, T., & Colonna, M.
- Affiliations
- Washington University in St. Louis (US)
- Alector (United States) (US)
- Corresponding author
- Schwabe, Tina
- Colonna, Marco
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2020-06-24
- Volume
- 217
- Issue
- 9
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC7478730
- OpenAlex
- W3037497912
- Cited by
- 549
- References
- 41
- Citations by year
- 2026: 106 · 2025: 115 · 2024: 101 · 2023: 93 · 2022: 64 · 2021: 52 · 2020: 18
- FWCI
- 21.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (RF1AG05148501, R21 AG059176, RF1 AG059082)
- Cure Alzheimer’s Fund
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- TREM2, Alzheimer's disease, microglial proliferation, amyloid plaques, microglial inflammation, transgenic mouse model, single-cell RNA sequencing, cerebrospinal fluid biomarkers, immunotherapy
- MeSH terms
- Alzheimer Disease, Animals, Antibodies, Monoclonal, Anxiety, Blood-Brain Barrier, Disease Models, Animal, Humans, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Transgenic, Protein Conformation, Receptors, Immunologic, Solubility, Signal Transduction, Biomarkers, Amyloid beta-Peptides, Neurites, Microglia, Cell Proliferation, Osteopontin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.